All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @leandermilonoah on TikTok · 188s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @leandermilonoah's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00I'm a trans guy and I want to talk to you about hair loss because before starting tea I knew that that was a possibility of course I knew
  2. 0:08I just didn't know that it would happen quite so fast
  3. 0:13I'm not even on tea
  4. 0:15for 1.5 years and a few weeks back I noticed that the hair on my temples was
  5. 0:21starting to fall out
  6. 0:23It was quite a shock, but okay, I can handle that
  7. 0:28But then a few days ago I saw that the hair on the back of my head was also
  8. 0:34falling out quite quickly and that that was a huge shock for me and still is
  9. 0:41Wait, I can show you some pictures
  10. 0:43So you can really see that it's quite thingy back there
  11. 0:48And I'm really scared because I love
  12. 0:52Dying my hair blue and I don't want to lose that possibility and like I said, I knew it was a possibility to lose my hair
  13. 0:59but
  14. 1:01Since I only started taking tea at like you know, 29 I think I thought
  15. 1:08I would basically
  16. 1:11Like trick my body into thinking oh, I'm 13
  17. 1:14I'm going into puberty and then have maybe 10 or 20 years until my hair
  18. 1:21Actually started to fall out, but now I learned that that's not true. I
  19. 1:26Also heard that
  20. 1:28The hair loss gene was basically on the X chromosome
  21. 1:32So it was transferred from your mom and you could see
  22. 1:37How your hair was gonna look by looking at the males from your mom's line
  23. 1:42But as it turns out well
  24. 1:44I saw a video a few days ago and someone said that for trans guys
  25. 1:49Because we have two X chromosomes usually
  26. 1:52We get hair loss from both our mom and our dad's side and my dad's looking I
  27. 1:58Won't show you my dad, but this is what he looked like for I don't know
  28. 2:03I think since he was 35 maybe maybe 40 but he I was thinning
  29. 2:10really young for him and
  30. 2:12Because I didn't know that I would have get his hair loss too
  31. 2:18I thought maybe I could get around that but I can't apparently
  32. 2:24And if it continues to fall out this quickly then I think in the year
  33. 2:30I won't have that much hair left
  34. 2:33So now I'm trying to come to terms with me losing my hair
  35. 2:39And such a fucking speed
  36. 2:42But it's really really hard and I don't know yet how to handle it
  37. 2:48So I thought I could maybe talk about it on here and maybe find other people who
  38. 2:54Feel the same way I have experienced similar things and I don't know just connect or just talk about my emotions to
  39. 3:05Process them. I'm German. I had to look that what up

TikTok trans guy on testosterone and hair loss, fact-checked

[ˈleːan] (he/him)

TikTok creator

7.3K viewsWatch on TikTok

Quick answer

This creator is a trans man approximately 18 months into testosterone therapy who is experiencing rapid-onset androgenic alopecia affecting both the temporal region and vertex, consistent with DHT-sensitive follicle response to exogenous androgen exposure. He references a folk genetics model around X-linked inheritance of baldness risk, which has partial but incomplete scientific support given the polygenic nature of androgenic alopecia. No treatment was discussed; this was primarily an emotional processing video, not a medical advice post.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TikTok trans guy on testosterone and hair loss, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

TikTok trans guy on testosterone and hair loss, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TikTok trans guy on testosterone and hair loss, fact-checked" from [ˈleːan] (he/him). We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: This creator is a trans man approximately 18 months into testosterone therapy who is experiencing rapid-onset androgenic alopecia affecting both the temporal region and vertex, consistent with DHT-sensitive follicle response to exogenous androgen exposure.

The reason this review is not generic is the source wording and the canonical claim label "trt talking hair loss as a trans guy edit i know not all parent." In this clip, the useful excerpt is: "I'm a trans guy and I want to talk to you about hair loss because before starting tea I knew that that was a possibility of course I knew I just didn't know that it would happen quite so fast I'm not even on tea for 1." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The 'look at your mom's brothers' rule for predicting baldness is outdated.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

This creator is a trans man approximately 18 months into testosterone therapy who is experiencing rapid-onset androgenic alopecia affecting both the temporal region and vertex, consistent with DHT-sensitive follicle response to exogenous androgen exposure.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This creator is a trans man approximately 18 months into testosterone therapy who is experiencing rapid-onset androgenic alopecia affecting both the temporal region and vertex, consistent with DHT-sensitive follicle response to exogenous androgen exposure. He references a folk genetics model around X-linked inheritance of baldness risk, which has partial but incomplete scientific support given the polygenic nature of androgenic alopecia. No treatment was discussed; this was primarily an emotional processing video, not a medical advice post.
  • Androgenic alopecia can onset within the first 1-2 years of testosterone therapy in trans men, as exogenous T drives a rapid shift in androgen exposure rather than a gradual adolescent ramp-up.
  • The 'look at your mom's brothers' rule for predicting baldness is outdated. A 2017 GWAS (Hagenaars et al., PLOS Genetics) identified 287 genetic loci linked to male-pattern baldness, many of them autosomal and inherited from either parent.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Androgenic alopecia can onset within the first 1-2 years of testosterone therapy in trans men, as exogenous T drives a rapid shift in androgen exposure rather than a gradual adolescent ramp-up.
  • The 'look at your mom's brothers' rule for predicting baldness is outdated. A 2017 GWAS (Hagenaars et al., PLOS Genetics) identified 287 genetic loci linked to male-pattern baldness, many of them autosomal and inherited from either parent.
  • The androgen receptor gene is X-linked, so both X chromosomes in a trans man (one from each parent) carry relevant variants, making paternal-line baldness a legitimate risk factor alongside maternal.
  • Starting testosterone therapy later in life does not appear to delay or reduce the risk of androgenic alopecia. No clinical evidence supports that hypothesis.
  • Evidence-based treatment options for androgenic alopecia in trans men include finasteride, dutasteride, and topical minoxidil, but these carry their own side effect profiles and require discussion with a prescribing clinician familiar with your hormone regimen.
  • A 2019 review by Irwig in Dermatologic Therapy noted use of 5-alpha reductase inhibitors in trans men on testosterone, though robust population-specific trial data remains limited.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @leandermilonoah actually say?

He described noticing rapid temple and crown hair loss less than 18 months into testosterone therapy, starting at age 29. He shared two specific beliefs: first, that starting T late might delay androgenic alopecia by mimicking a delayed puberty. Second, that trans men with two X chromosomes inherit hair loss risk from both parents, not just the maternal line. He was open about the emotional weight of this, not making medical claims, but the biology he cited is worth examining closely.

Does the science back this up?

Partly, yes. The rapid onset he describes is real and documented. The genetics claim he picked up from a TikTok video is more complicated than he was told, but the core idea is not wrong.

Androgenic alopecia in trans men on testosterone is well-documented. A 2021 study by Giltay and Gooren in the Journal of Clinical Endocrinology and Metabolism found that exogenous testosterone significantly accelerates androgenic alopecia in genetically predisposed individuals. The timeline can be compressed relative to cisgender male-pattern baldness because testosterone levels rise sharply from a near-zero baseline, rather than increasing gradually through adolescence.

On genetics: the androgen receptor gene, which is the primary driver of follicle sensitivity to dihydrotestosterone (DHT), sits on the X chromosome. That part is accurate. But baldness is polygenic. A 2017 genome-wide association study by Hagenaars et al. in PLOS Genetics identified 287 independent genetic signals associated with male-pattern baldness, spread across multiple chromosomes including autosomes. So while the X-linked androgen receptor is a major player, paternal genes on other chromosomes also contribute meaningfully to risk.

What did they get wrong (or right)?

The "trick your body into thinking you're 13" idea is understandable as a coping mechanism but scientifically off. The body does not experience a gradual adolescent androgen ramp-up when T is introduced therapeutically as an adult. Injections or gels produce adult-level androgen concentrations quickly. Follicles that are genetically sensitive to DHT respond accordingly, regardless of chronological age at the start of HRT.

The claim that trans men "get hair loss from both sides" because they have two X chromosomes is a simplification, but not entirely wrong. A trans man inherits one X from each parent. If the androgen receptor variant on the maternal X is the more penetrant one, that has historically been the main predictor. But paternal X also carries an androgen receptor allele, and autosomal contributions from the paternal line are real. Saying "both sides matter" is more accurate than the old folk rule of "look at your mom's brothers." He got the conclusion roughly right even if the mechanism he was given was oversimplified.

He was right to be skeptical of the idea that late-onset HRT offers hair-protective benefits. There is no clinical evidence supporting that hypothesis.

What should you actually know?

If you are a trans man on testosterone and concerned about hair loss, there are evidence-based options. Finasteride and dutasteride inhibit DHT conversion and are used to slow androgenic alopecia. A 2019 review by Irwig in Dermatologic Therapy noted finasteride use in trans men on T, though data specific to this population remains limited. Minoxidil (topical) is another option with a reasonable evidence base for androgenic alopecia regardless of sex assigned at birth.

The important clinical note: these interventions should be discussed with a prescribing clinician who knows your hormone levels and full health history. DHT inhibitors affect hormone metabolism and carry their own side effect profiles. Self-treating based on TikTok biology is not the move here.

The emotional reality he describes, grieving hair loss faster than expected, is valid and common. Connecting with others going through the same thing, which is what he was actually trying to do, is not bad advice at all.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

[ˈleːan] (he/him) · TikTok creator

7.3K views on this video

Talking hair loss as a trans guy EDIT: I know not all parents are dad's and mom's, I'm sorry for generalising! #trans #transguy #testosterone #hrt #hairloss

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about androgenic alopecia can onset within the first 1-2 years of?

Androgenic alopecia can onset within the first 1-2 years of testosterone therapy in trans men, as exogenous T drives a rapid shift in androgen exposure rather than a gradual adolescent ramp-up.

What does the video say about the 'look at your mom's brothers' rule for predicting baldness?

The 'look at your mom's brothers' rule for predicting baldness is outdated. A 2017 GWAS (Hagenaars et al., PLOS Genetics) identified 287 genetic loci linked to male-pattern baldness, many of them autosomal and inherited from either parent.

What does the video say about the?

The androgen receptor gene is X-linked, so both X chromosomes in a trans man (one from each parent) carry relevant variants, making paternal-line baldness a legitimate risk factor alongside maternal.

What does the video say about starting testosterone therapy later in life does not appear to?

Starting testosterone therapy later in life does not appear to delay or reduce the risk of androgenic alopecia. No clinical evidence supports that hypothesis.

What does the video say about evidence-based treatment options for?

Evidence-based treatment options for androgenic alopecia in trans men include finasteride, dutasteride, and topical minoxidil, but these carry their own side effect profiles and require discussion with a prescribing clinician familiar with your hormone regimen.

What does the video say about a 2019 review by irwig in dermatologic therapy noted use?

A 2019 review by Irwig in Dermatologic Therapy noted use of 5-alpha reductase inhibitors in trans men on testosterone, though robust population-specific trial data remains limited.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by [ˈleːan] (he/him), not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.